Michael H. A. Roehrl

ORCID: 0000-0003-4892-1098
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Colorectal Cancer Treatments and Studies
  • Epigenetics and DNA Methylation
  • Neuroendocrine Tumor Research Advances
  • RNA modifications and cancer
  • Advanced Proteomics Techniques and Applications
  • Glycosylation and Glycoproteins Research
  • Colorectal and Anal Carcinomas
  • Immunotherapy and Immune Responses
  • Lung Cancer Treatments and Mutations
  • Monoclonal and Polyclonal Antibodies Research
  • Ubiquitin and proteasome pathways
  • Molecular Biology Techniques and Applications
  • Systemic Lupus Erythematosus Research
  • Diabetes and associated disorders
  • Ferroptosis and cancer prognosis
  • Renal cell carcinoma treatment
  • Signaling Pathways in Disease
  • Genomics and Chromatin Dynamics
  • T-cell and B-cell Immunology
  • Evolution and Genetic Dynamics

Harvard University
2003-2025

Beth Israel Deaconess Medical Center
2023-2025

Memorial Sloan Kettering Cancer Center
2016-2024

University Health Network
2014-2024

University of Toronto
2014-2024

Hadassah Medical Center
2024

Okayama University
2024

Kawasaki Medical School
2024

Princess Margaret Cancer Centre
2015-2024

Lemuel Shattuck Hospital
2024

Franck Pagès Bernhard Mlecnik Florence Marliot Gabriela Bindea Fang‐Shu Ou and 94 more Carlo Bifulco Alessandro Lugli Inti Zlobec Tilman T. Rau Martin D. Berger Irıs D. Nagtegaal Elisa Vink‐Börger Arndt Hartmann Carol I. Geppert Julie Kolwelter Susanne Merkel Robert Grützmann Marc Van den Eynde Anne Jouret‐Mourin Alex Kartheuser Daniel Léonard Christophe Remue Julia Y. Wang Prashant Bavi Michael H. A. Roehrl Pamela S. Ohashi Linh T. Nguyen SeongJun Han Heather MacGregor Sara Hafezi‐Bakhtiari Bradly G. Wouters Giuseppe Masucci Emilia Andersson Eva Závadová Michal Vočka Jan Špaček Luboš Petruželka B Konopásek Pavel Dundr Helena Skálová Kristýna Němejcová Gerardo Botti Fabiana Tatangelo Paolo Delrio Gennaro Ciliberto Michele Maio Luigi Laghi Fabio Grizzi Tessa Fredriksen Bénédicte Buttard Mihaela Angelova Angela Vasaturo Pauline Maby Sarah E. Church Helen K. Angell Lucie Lafontaine Daniela Bruni Carine El Sissy Nacilla Haicheur Amos Kirilovsky Anne Berger Christine Lagorce Jeffrey P. Meyers Christopher Paustian Zipei Feng Carmen Ballesteros‐Merino Jeroen R. Dijkstra Carlijn van de Water Shannon van Vliet Nikki Knijn Ana-Maria Muşină Dragoş Viorel Scripcariu Boryana Konstantinova Popivanova Mingli Xu Tomonobu Fujita Shoichi Hazama Nobuaki Suzuki Hiroaki Nagano Kiyotaka Okuno Toshihiko Torigoe Noriyuki Sato Tomohisa Furuhata Ichiro Takemasa Kyogo Itoh Prabhudas S. Patel Hemangini H. Vora Birva Shah Jayendrakumar B. Patel Kruti N. Rajvik Shashank Pandya Shilin N. Shukla Yili Wang Guanjun Zhang Yutaka Kawakami Francesco M. Marincola Paolo A. Ascierto Daniel J. Sargent Bernard A. Fox Jérôme Galon

10.1016/s0140-6736(18)30789-x article EN The Lancet 2018-05-01
Ayuko Hoshino Han Sang Kim Linda Bojmar Kofi Ennu Gyan Michele Cioffi and 95 more Jonathan M. Hernandez Constantinos P. Zambirinis Gonçalo Rodrigues Henrik Molina Søren Heissel Milica Tešić Mark Loïc Steiner Alberto Benito‐Martín Serena Lucotti Angela Di Giannatale Katharine Offer Miho Nakajima Caitlin Williams Laura Nogués Fanny A. Pelissier Vatter Ayako Hashimoto Alexander E. Davies Daniela Freitas Candia M. Kenific Yonathan Ararso Weston Buehring Pernille Lauritzen Yusuke Ogitani Kei Sugiura Naoko Takahashi Maša Alečković Kayleen Bailey Joshua S. Jolissant Huajuan Wang Ashton Harris Laurent Schaeffer Guillermo García‐Santos Zoe Posner Vinod P. Balachandran Yasmin Khakoo G. Praveen Raju Avigdor Scherz Irit Sagi Ruth Scherz‐Shouval Yosef Yarden Moshe Oren Mahathi Malladi Mary Petriccione Kevin C. De Braganca Maria Donzelli Cheryl Fischer Stephanie Vitolano Geraldine P. Wright Lee Ganshaw Mariel Marrano Amina Ahmed Joe DeStefano Enrico Danzer Michael H. A. Roehrl Norman J. Lacayo Theresa C. Vincent Martin R. Weiser Mary S. Brady Paul A. Meyers Leonard H. Wexler Srikanth Ambati Alexander J. Chou Emily K. Slotkin Shakeel Modak Stephen S. Roberts Ellen M. Basu Daniel Diolaiti Benjamin A. Krantz Fátima Cardoso Amber L. Simpson Michael F. Berger Charles M. Rudin Diane M. Simeone Maneesh Jain Cyrus M. Ghajar Surinder K. Batra Ben Z. Stanger Jack D. Bui Kristy A. Brown Vinagolu K. Rajasekhar John H. Healey Maria de Sousa Kim Kramer Sujit Sheth Jeanine Baisch Virginia Pascual Todd E. Heaton Michael P. LaQuaglia David J. Pisapia Robert E. Schwartz Haiying Zhang Yuan Liu Arti Shukla Laurence Blavier Yves A. DeClerck

10.1016/j.cell.2020.07.009 article EN publisher-specific-oa Cell 2020-08-01
Liwei Cao Chen Huang Daniel Cui Zhou Yingwei Hu T. Mamie Lih and 95 more Sara R. Savage Karsten Krug David Clark Michael Schnaubelt Lijun Chen Felipe da Veiga Leprevost Rodrigo Vargas Eguez Weiming Yang Jianbo Pan Bo Wen Yongchao Dou Wen Jiang Yuxing Liao Zhiao Shi Nadezhda V. Terekhanova Song Cao Rita Jui-Hsien Lu Yize Li Ruiyang Liu Houxiang Zhu Peter Ronning Yige Wu Matthew A. Wyczalkowski Hariharan Easwaran Ludmila Danilova Arvind Singh Mer Seungyeul Yoo Joshua M. Wang Wenke Liu Benjamin Haibe‐Kains Mathangi Thiagarajan Scott D. Jewell Galen Hostetter Chelsea J. Newton Qing Kay Li Michael H. A. Roehrl David Fenyö Pei Wang Alexey I. Nesvizhskii D.R. Mani Gilbert S. Omenn Emily S. Boja Mehdi Mesri Ana I. Robles Henry Rodriguez Oliver F. Bathe Daniel W. Chan Ralph H. Hruban Li Ding Bing Zhang Hui Zhang Mitual Amin Eunkyung An Christina Ayad Thomas Bauer Chet Birger Michael J. Birrer Simina M. Boca William Bocik Melissa Borucki Shuang Cai Steven A. Carr Sandra Cerda Huan Chen Steven Chen David Chesla Arul M. Chinnaiyan Antonio Colaprico Sandra Cottingham Magdalena Derejska Saravana M. Dhanasekaran Marcin J. Domagalski Brian J. Druker Elizabeth R. Duffy Maureen A. Dyer Nathan Edwards Matthew J. Ellis Jennifer Eschbacher Alicia Francis Jesse Francis Stacey Gabriel N Gabrovski Johanna Gardner Gad Getz Michael A. Gillette Charles A. Goldthwaite Pamela Grady Shuai Guo Pushpa Hariharan Tara Hiltke Barbara Hindenach Katherine A. Hoadley Jasmine Huang Corbin D. Jones Karen A. Ketchum

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient survival. Toward understanding the underlying molecular alterations that drive PDAC oncogenesis, we conducted comprehensive proteogenomic analysis of 140 pancreatic cancers, 67 normal adjacent tissues, and 9 tissues. Proteomic, phosphoproteomic, glycoproteomic analyses were used to characterize proteins their modifications. In addition, whole-genome sequencing, whole-exome methylation, RNA sequencing...

10.1016/j.cell.2021.08.023 article EN cc-by Cell 2021-09-01

Avian Flu in Ferrets A recent outbreak of avian H7N9 influenza humans eastern China has been closely monitored for any evidence human-to-human transmission and its potential sparking a pandemic. Zhu et al. (p. 183 , published online 23 May) examined the behavior virus ferret, mammalian model human influenza. The was excreted by ferrets could be transmitted readily contact but displayed limited capacity airborne infectivity. pathology is similar to H1N1, it seems that factors other than...

10.1126/science.1239844 article EN Science 2013-05-24

The clinical utility of molecular profiling tumor tissue to guide treatment patients with advanced solid tumors is unknown. Our objectives were evaluate the frequency genomic alterations, "actionability" somatic variants, enrollment in mutation-targeted or other trials, and outcome for at Princess Margaret Cancer Centre (PM). Patients aged ≥18 years, good performance status, archival available prospectively consented. DNA from formalin-fixed paraffin-embedded was tested using a MALDI-TOF MS...

10.1186/s13073-016-0364-2 article EN cc-by Genome Medicine 2016-10-25

<h3>Importance</h3> Outcomes for patients with pancreatic ductal adenocarcinoma (PDAC) remain poor. Advances in next-generation sequencing provide a route to therapeutic approaches, and integrating DNA RNA analysis clinicopathologic data may be crucial step toward personalized treatment strategies this disease. <h3>Objective</h3> To classify PDAC according distinct mutational processes, explore their clinical significance. <h3>Design, Setting, Participants</h3> We performed retrospective...

10.1001/jamaoncol.2016.3916 article EN JAMA Oncology 2016-10-20
Bernhard Mlecnik Carlo Bifulco Gabriela Bindea Florence Marliot Alessandro Lugli and 87 more J. Jack Lee Inti Zlobec Tilman T. Rau Martin D. Berger Irıs D. Nagtegaal Elisa Vink‐Börger Arndt Hartmann Carol I. Geppert Julie Kolwelter Susanne Merkel Robert Grützmann Marc Van den Eynde Anne Jouret‐Mourin Alex Kartheuser Daniel Léonard Christophe Remue Julia Y. Wang Prashant Bavi Michael H. A. Roehrl Pamela S. Ohashi Linh T. Nguyen SeongJun Han Heather MacGregor Sara Hafezi‐Bakhtiari Bradly G. Wouters Giuseppe Masucci Emilia Andersson Eva Závadová Michal Vočka Jan Špaček Luboš Petruželka B Konopásek Pavel Dundr Helena Skálová Kristýna Němejcová Gerardo Botti Fabiana Tatangelo Paolo Delrio Gennaro Ciliberto Michele Maio Luigi Laghi Fabio Grizzi Tessa Fredriksen Bénédicte Buttard Lucie Lafontaine Daniela Bruni Anastasia Lanzi Carine El Sissy Nacilla Haicheur Amos Kirilovsky Anne Berger Christine Lagorce Christopher Paustian Carmen Ballesteros‐Merino Jeroen R. Dijkstra Carlijn van de Water Shannon van Vliet Nikki Knijn Ana-Maria Muşină Dragoş Viorel Scripcariu Boryana Konstantinova Popivanova Mingli Xu Tomonobu Fujita Shoichi Hazama Nobuaki Suzuki Hiroaki Nagano Kiyotaka Okuno Toshihiko Torigoe Noriyuki Sato Tomohisa Furuhata Ichiro Takemasa Kyogo Itoh Prabhudas S. Patel Hemangini H. Vora Birva Shah Jayendrakumar B. Patel Kruti N. Rajvik Shashank Pandya Shilin N. Shukla Yili Wang Guanjun Zhang Yutaka Kawakami Francesco M. Marincola Paolo A. Ascierto Bernard A. Fox Franck Pagès Jérôme Galon

The purpose of this study was to evaluate the prognostic value Immunoscore in patients with stage III colon cancer (CC) and analyze its association effect chemotherapy on time recurrence (TTR).

10.1200/jco.19.03205 article EN Journal of Clinical Oncology 2020-09-08

Equilibrium binding experiments are widely used for the accurate characterization of and competitive behavior in biological systems. Modern high-throughput discovery efforts chemical biology rely heavily upon this principle. Here, we derive exact analytical expressions general models which can also explain a commonly encountered phenomenon these types experiments, anticooperative incomplete displacement. We explore effects nonspecific parameter misestimation. All derived terms total...

10.1021/bi048233g article EN Biochemistry 2004-11-26

The combinatorial action of separate cis-acting elements controls the cell-specific expression type I collagen genes. In particular, we have shown that two short located between -3.2 and -2.3 kb named TSE1 TSE2 are needed for mouse COL1a1 gene in tendon fibroblasts. this study, analyzed trans-acting factors binding to TSE2. Gel shift experiments showed scleraxis (SCX), which is a basic helix-loop-helix transcription factor expressed selectively fibroblasts, binds TSE2, preferentially as...

10.1074/jbc.m610113200 article EN cc-by Journal of Biological Chemistry 2007-04-13

Lineage plasticity is implicated in treatment resistance multiple cancers. In lung adenocarcinomas (LUAD) amenable to targeted therapy, transformation small cell cancer (SCLC) a recognized mechanism. Defining molecular mechanisms of neuroendocrine (NE) has been limited by paucity pre/posttransformation clinical samples. Detailed genomic, epigenomic, transcriptomic, and protein characterization combined LUAD/SCLC tumors, as well samples, supports that NE primarily driven transcriptional...

10.1158/2159-8290.cd-20-1863 article EN Cancer Discovery 2021-06-21

Broad adoption of digital pathology (DP) is still lacking, and examples for DP connecting diagnostic, research, educational use cases are missing. We blueprint a holistic solution at large academic medical center ubiquitously integrated into clinical workflows; researchapplications including molecular, genetic, tissue databases; processes.

10.1093/jamia/ocab085 article EN cc-by Journal of the American Medical Informatics Association 2021-05-04

Abstract The utility of cancer whole genome and transcriptome sequencing (cWGTS) in oncology is increasingly recognized. However, implementation cWGTS challenged by the need to deliver results within clinically relevant timeframes, concerns about assay sensitivity, reporting prioritization findings. In a prospective research study we develop workflow that reports comprehensive 9 days. Comparison diagnostic panel assays demonstrates potential capture all reported mutations with comparable...

10.1038/s41467-022-30233-7 article EN cc-by Nature Communications 2022-05-18

Since 2010, the Human Proteome Project (HPP), flagship initiative of Organization (HUPO), has pursued two goals: (1) to credibly identify protein parts list and (2) make proteomics an integral part multiomics studies human health disease. The HPP relies on international collaboration, data sharing, standardized reanalysis MS sets by PeptideAtlas MassIVE-KB using Guidelines for quality assurance, integration curation non-MS neXtProt, plus extensive use antibody profiling carried out Protein...

10.1021/acs.jproteome.3c00591 article EN Journal of Proteome Research 2024-01-17

Transient or reversible protein–protein interactions are commonly used to ensure efficient targeting of signaling enzymes their cellular substrates. These include direct binding substrate, interaction with an accessory scaffold protein, and positioning at subcellular locations in proximity The existence specialized mechanisms raises the possibility designing inhibitors that do not block enzyme activity per se , but rather interfere one more its substrates within cell. Here, we identify small...

10.1073/pnas.0401835101 article EN Proceedings of the National Academy of Sciences 2004-05-06

Discovery of tissue-specific biomarkers for human cancer is crucial early diagnosis and molecular understanding the disease. To overcome limitations posed by large dynamic concentration range compositional complexity tissue biomacromolecules, we applied heparin affinity fractionation proteomic enrichment. Comparing proteomes five paired samples normal lung pulmonary adenocarcinoma 2-D difference gel electrophoresis, 14 spots were found to be differentially expressed. From these candidate...

10.1021/pr900705r article EN Journal of Proteome Research 2009-10-22

3500 Background: Mounting evidence indicates an enhanced lymphocytic reaction as informative prognostic indicator in colon cancer (CC). The IM methodology has been defined to quantify the situ immune infiltrate. Methods: A Society for Immunotherapy of Cancer-led international consortium 23 pathology expert centers from 17 countries was initiated evaluate standardized assay routine clinical settings. Patient (pt) eligibility criteria were CC Stages I/II/III and no neo-adjuvant treatment. 1336...

10.1200/jco.2016.34.15_suppl.3500 article EN Journal of Clinical Oncology 2016-05-20

Immunotherapy with monoclonal antibodies targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4) or programmed cell death 1 (PD-1) has improved the survival of patients metastatic melanoma. These agents carry a certain risk adverse immune-related events. We present patient widely melanoma who was initially treated ipilimumab and subsequently nivolumab. After four infusions nivolumab, he developed subacute multifocal central nervous system (CNS) demyelination. Nivolumab discontinued and, despite...

10.1158/2326-6066.cir-15-0141 article EN Cancer Immunology Research 2015-09-30
Coming Soon ...